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The estrogen receptor α (ERα) regulates the transcription of target genes by recruiting coregulator proteins
through several domains including the two activation functions AF1 and AF2.The contribution of the
N-terminally located AF1 activity is particularly important in differentiated cells, and for ERα to integrate inputs
from other signaling pathways. However, how the phosphorylation of key residues influences AF1 activity
has long remained mysterious, in part because the naturally disordered AF1 domain has resisted a structural
characterization.The recent discovery of two coregulators that are specific for a phosphorylated form of AF1
suggests that phosphorylation, possibly in conjunction with the subsequent binding of these coregulators,
may enforce a stable structure.The binding of the "pioneer" coregulators might facilitate the subsequent
recruitment of yet other coregulators. Different AF1 folds may be enabled by the combinatorial action of
posttranslational modifications and coregulator binding thereby fine-tuning ERα activities in a cell- and
promoter-specific fashion.
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Introduction
ERα is a member of the nuclear receptor superfamily,
and mediates the responses to estrogens as well as a
variety of other extracellular signals by signaling crosstalk.
As a nuclear receptor, it harbors a receptor function,
DNA-binding capacity and transcriptional activation
functions all within the same molecule.Transcriptional
regulation by ERα is mediated by the two activation
functions AF1 and AF2.These activation functions
represent docking surfaces on the receptor through which
corepressors and coactivators are recruited.The
particular combination of recruited coregulators
determines the assembly of the general transcription
machinery on the promoter and the resulting gene
expression pattern.
AF2 lies within the ligand binding domain (LBD) of ERα
and is induced upon binding of an agonist [Nagy and
Schwabe, 2004; Steinmetz et al., 2001]. Depending on
the exact chemical nature of the ligand and the precise
allosteric rearrangements it induces in the LBD,
coactivators or corepressors are recruited [Nettles and
Greene, 2005].The AF1 domain is located in the
N-terminal region of ERα.The intrinsically constitutive
activity of AF1 is unleashed by agonist binding to the
LBD, but various signaling pathways also stimulate its
activity, in part by direct phosphorylation of several
serines [Ali et al., 1993; Bunone et al., 1996; Chen et al.,
2000; Kato et al., 1995] (see also below).To the extent
that AF1 can be dissected at all, different regions of AF1
have been shown to have distinct cell-type and promoter
selectivity [McInerney and Katzenellenbogen, 1996;
Metivier et al., 2000; Metzger et al., 1995;Tora et al.,
1989].
Signaling crosstalk involves
phosphorylation of AF1
During the last fifteen years, many investigators have
reported that crosstalk between steroid- and growth
factor-stimulated intracellular signaling pathways can
affect the activity of nuclear receptors, and as a
consequence the transcription of target genes [Cenni and
Picard, 1999; Picard, 2003;Weigel and Zhang, 1998]. In
the case of ERα, this involves the direct phosphorylation
of the receptor, coactivators, and/or other regulatory
proteins. A whole series of amino acid residues of ERα
display basal and induced phosphorylation in response
to ligands, growth factors and other regulatory molecules
by MAPK, AKT, Rsk, protein kinases A and C, casein
kinase II, CDK2, and CDK7 [Ali et al., 1993; Bunone et
al., 1996; Campbell et al., 2001; Chen et al., 2000; Clark
et al., 2001; Joel et al., 1998; Kato et al., 1995;Le Goff
et al., 1994; Martin et al., 2000; Rogatsky et al., 1999;
Tremblay et al., 1999] . Our understanding of the roles
of all of these kinases and phosphorylation sites remains
unclear. As far as AF1 is concerned, serine 118 (S118;
numbering according to the sequence of the human ERα)
is the main phosphorylation site that needs to be
considered.
Specific recruitment of coregulators by
the phosphorylated AF1
The key question is how the phosphorylation of ERα AF1
modulates its transcriptional activity.The mechanistic
answer might depend on how this phosphorylation comes
about, and on whether or not AF2 is also activated by
cognate hormone, but it seemed reasonable from the
beginning to speculate that the phosphorylation of S118
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serious candidates took a long time to be identified.
Although the recruitment of p68 RNA helicase is
stimulated by phosphorylation of S118, its stimulation of
ERα activity is relatively weak, cell-specific and not strictly
phospho-S118-dependent [Endoh et al., 1999;Watanabe
et al., 2001]. A much more serious contender is the
recently reported splicing factor SF3a120, a component
of the U2 snRNP [Masuhiro et al., 2005]. Binding of
SF3a120 to ERα, and stimulation of ERα activity by
SF3a120 is fully dependent on the phosphorylation of
S118. Moreover, SF3a120 promotes the effects of ERα
on splicing of transcripts made from ERα target genes,
and again this effect is dependent on the phosphorylation
of S118.Thus, the recruitment of SF3a120 may account
for much of the stimulatory effects of the phosphorylation
of S118.
Surprisingly, the phosphorylation of S118 also allows the
recruitment of a corepressor.We recently discovered the
stromelysin-1 platelet-derived growth factor-responsive
element-binding protein (SPBP) as the first protein whose
binding to ERα is strictly dependent on phosphoserine
118 [Gburcik et al., 2005]. Unlike p68 and SF3a120,
SPBP functionally behaves as a corepressor of activated
ERα.We have speculated that the role of SPBP might
be to attenuate the activity of AF1, and to allow only a
transient activation.
Recruitment by phosphorylation
-induced structural gymnastics
In contrast to other nuclear receptor domains, there are
no high-resolution structures available to date for the AF1
domain of any member of the nuclear receptor
superfamily [Lavery and McEwan, 2005]. Its structure
may be naturally disordered. AF1 domains appear to be
structurally flexible with little stable secondary structure.
This structural flexibility may provide the possibility for
multiple different interactions [Dunker et al., 2002; Dyson
and Wright, 2005]. Since different partner proteins may
induce different conformations, they may in turn depend
on cellular and promoter context. Moreover, it is possible
that the AF1 domain requires specific post-translational
modifications in order to be fully active [Kumar and
Thompson, 2003]. Phosphorylation of AF1 may increase
its helical content, which has been shown to correlate
with increased activation potency in case of the
peroxisome-proliferator activated receptors (PPARs)
[Gelman et al., 2005].
Are SF3a120 or SPBP novel phosphoserine binding
proteins? Competition and truncation experiments (data
not shown) suggest that SPBP recognizes a specific AF1
fold induced by phosphorylation rather than the immediate
context of the phosphorylated serine itself (see Figure 1).
If we hypothesize that the phosphorylation of AF1 induces
a conformational change or stabilization resulting in the
generation of a docking site for a cofactor, several
predictions are worth considering. Cofactors that interact
with the phosphorylated AF1 might facilitate each other's
recruitment (Figure 1A). Anchoring one cofactor might
further stabilize or structure the domain [Gelman et al.,
2005; Lavery and McEwan, 2005], and allow the
subsequent binding of a second factor (Figure 1B and
C).
In a different context, it had already been suggested that
the recruitment of coactivators could facilitate the
subsequent recruitment of other coactivators or even
corepressors [Perissi and Rosenfeld, 2005]. Indeed, some
of our preliminary results with combinations of SPBP and
coactivators support this speculation (data not shown).
We suggest that upon AF1 phosphorylation, coactivators
such as SF3a120 are recruited first.They then facilitate
the recruitment of SPBP, which acts as a corepressor,
most likely by recruiting other corepressors such as NCoR
[Gburcik et al., 2005].The end result is that the strength
and the duration of ERα activity are dampened. In this
and other situations, alternative scenarios with an inverse
order of binding or with cyclical exchanges are also
conceivable.
This phosphorylation-induced gymnastics may itself be
influenced by and complement additional "outside" inputs
into AF1 structure. For example, binding of JDP-2 to the
DNA binding domain of the progesterone receptor
increases the helical contents of the N-terminus and AF-1
activity [Wardell et al., 2005], and sequence-specific
allosteric effects of the DNA response element on
receptor conformation have been recognized as a general
principle for several nuclear receptors [Lefstin and
Yamamoto, 1998] including ERα [Wood et al., 1998].
Physiological implications
There may be many physiological consequences of this
structural gymnastics induced by signaling crosstalk.To
illustrate this point it should be sufficient to mention a few.
In differentiated cells, AF1 may be the major
transactivation function of ERα [Merot et al., 2004;
Pendaries et al., 2002].Therefore, SPBP might be an
important determinant of the cell-specific activity pattern
of ERα in differentiated cells. It might also play an
important role in the organ-specific activity pattern of ERα
during the estrous cycle, which has recently been
monitored in a transgenic mouse model with a luciferase
reporter gene under the control of activated ERs [Ciana
et al., 2003]. Interestingly, the reporter activity in
reproductive organs was synchronized with estrogen
levels, while the peak of ER-dependent activity in
non-reproductive organs did not correlate with estrogen
levels. It was speculated that the latter activity might be
due to ligand-independent activation of ERs by growth
factors such as IGF-I.Whereas SPBP is not expressed
in reproductive organs [Rekdal et al., 2000], the
expression of SPBP might be cyclically induced in
non-reproductive organs during the estrous cycle
repressing ERα activity when estrogen peaks.
Signaling crosstalk of ERα with growth factors is also
thought to contribute to resistance to endocrine therapy
in breast cancer by stimulating AF1 phosphorylation and
activity [Osborne et al., 2003; Osborne et al., 2005; Shou
et al., 2004]. Hence, antiestrogen-resistant ERα-positive
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each other's recruitment by stabilizing the specific fold of phosphorylated AF1. (b) Binding of one coregulator stabilizes a particular AF1 structure and
allows the subsequent recruitment of another coregulator. (c) A second coregulator recognizes both the newly induced AF1 structure and coregulator
1.
breast tumors would be expected to have lower SPBP
levels. In contrast, ERα-negative breast tumors would
not be adversely affected by the presence of SPBP.
Rather they would benefit from the activating effects of
SPBP on other growth-promoting transcription factors
such as c-Jun [Rekdal et al., 2000]. Indeed, as we have
previously pointed out [Gburcik et al., 2005], this inverse
correlation between SPBP and ERα expression can be
seen in a microarray analysis of breast tumor samples
[van 't Veer et al., 2002].
Outlook
The models discussed in this essay have several practical
as well as biological implications. For example, the
identification of certain AF1 coregulators may only be
possible in the presence of a first-line coregulator.
Moreover, solving the structure of AF1 may require
solving the structure of a complex between a
phosphorylated AF1 and a coregulator. At a more
mechanistic and physiological level, it will be interesting
to fill in the details of how signaling crosstalk induces
structural changes in AF1, and how this contributes to
specifying and fine-tuning the physiological functions of
ERα.
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